首页> 外文期刊>BMC Musculoskeletal Disorders >A treatment applying a biomechanical device to the feet of patients with knee osteoarthritis results in reduced pain and improved function: a prospective controlled study
【24h】

A treatment applying a biomechanical device to the feet of patients with knee osteoarthritis results in reduced pain and improved function: a prospective controlled study

机译:将生物机械设备应用于膝骨关节炎患者脚部的治疗可减轻疼痛并改善功能:一项前瞻性对照研究

获取原文
       

摘要

Background This study examined the effect of treatment with a novel biomechanical device on the level of pain and function in patients with knee OA. Methods Patients with bilateral knee OA were enrolled to active and control groups. Patients were evaluated at baseline, at 4 weeks and at the 8-week endpoint. A novel biomechanical device was individually calibrated to patients from the active group. Patients from the control group received an identical foot-worn platform without the biomechanical elements. Primary outcomes were the WOMAC Index and ALF assessments. Results There were no baseline differences between the groups. At 8 weeks, the active group showed a mean improvement of 64.8% on the WOMAC pain scale, a mean improvement of 62.7% on the WOMAC function scale, and a mean improvement of 31.4% on the ALF scale. The control group demonstrated no improvement in the above parameters. Significant differences were found between the active and control groups in all the parameters of assessment. Conclusions The biomechanical device and treatment methodology is effective in significantly reducing pain and improving function in knee OA patients. The study is registered at clinicaltrials.gov, identifier NCT00457132, http://www.clinicaltrials.gov/ct/show/NCT00457132?order=1
机译:背景技术这项研究检查了新型生物力学设备对膝骨关节炎患者疼痛和功能水平的影响。方法将双侧膝骨关节炎患者分为活动组和对照组。在基线,第4周和第8周终点对患者进行评估。新型的生物力学设备已针对活动组的患者进行了单独校准。对照组的患者接受了完全相同的脚踩平台,没有生物力学元素。主要结果是WOMAC指数和ALF评估。结果两组之间没有基线差异。在第8周时,活动组在WOMAC疼痛量表上显示平均改善64.8%,在WOMAC功能量表上显示平均改善62.7%,在ALF量表上显示平均31.4%。对照组在上述参数上没有改善。在所有评估参数中,活动组与对照组之间存在显着差异。结论该生物力学装置和治疗方法可有效减轻膝骨OA患者的疼痛并改善其功能。该研究已在Clinicaltrials.gov上注册,标识为NCT00457132,http://www.clinicaltrials.gov/ct/show/NCT00457132?order = 1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号